CardiologyOnline.net

Cardiology Xagena

Xagena Mappa
Medical Meeting
Cardiobase
Gastrobase.it

Search results for "Savaysa"

Edoxaban ( Savaysa ) is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of Edoxaban as compared with Warfarin ( Coumadin ) in patients with atri ...


At the end of two previous trials, an excess of stroke and bleeding was observed in patients with atrial fibrillation randomized to a new oral anticoagulant ( NOAC ) who transitioned to a vitamin K an ...


The aim of a study was to evaluate the population pharmacokinetics ( PK ) and exposure-response relationship of Edoxaban ( Lixiana, Savaysa ) in patients with non-valvular atrial fibrillation ( AF ). ...


New oral anticoagulants for stroke prevention in atrial fibrillation were developed to be given in fixed doses without the need for the routine monitoring that has hindered usage and acceptance of vit ...


In the ENGAGE AF-TIMI 48 trial, the higher-dose Edoxaban ( HDE; Lixiana, Savaysa ) regimen had a similar incidence of ischaemic stroke compared with Warfarin ( Coumadin ), whereas a higher incidence w ...